These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2884050)
1. Ethoxyquin alone induces preneoplastic changes in rat kidney whilst preventing induction of such lesions in liver by aflatoxin B1. Manson MM; Green JA; Driver HE Carcinogenesis; 1987 May; 8(5):723-8. PubMed ID: 2884050 [TBL] [Abstract][Full Text] [Related]
2. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884 [TBL] [Abstract][Full Text] [Related]
3. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat. Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284 [TBL] [Abstract][Full Text] [Related]
4. Induction of gamma-glutamyl transpeptidase mRNA by aflatoxin B1 and ethoxyquin in rat liver. Power CA; Griffiths SA; Simpson JL; Laperche Y; Guellaen G; Manson MM Carcinogenesis; 1987 May; 8(5):737-40. PubMed ID: 2884051 [TBL] [Abstract][Full Text] [Related]
5. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase. Thamavit W; Tatematsu M; Ogiso T; Mera Y; Tsuda H; Ito N Cancer Lett; 1985 Jul; 27(3):295-303. PubMed ID: 2861889 [TBL] [Abstract][Full Text] [Related]
8. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cabral JR; Neal GE Cancer Lett; 1983 Jun; 19(2):125-32. PubMed ID: 6411325 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111 [TBL] [Abstract][Full Text] [Related]
10. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Hayes JD; Judah DJ; Neal GE Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers. Manson MM; Hudson EA; Ball HW; Barrett MC; Clark HL; Judah DJ; Verschoyle RD; Neal GE Carcinogenesis; 1998 Oct; 19(10):1829-36. PubMed ID: 9806166 [TBL] [Abstract][Full Text] [Related]
12. Dietary protein level and aflatoxin B1-induced preneoplastic hepatic lesions in the rat. Dunaif GE; Campbell TC J Nutr; 1987 Jul; 117(7):1298-302. PubMed ID: 2886567 [TBL] [Abstract][Full Text] [Related]
13. Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia. Shepherd AG; Manson MM; Ball HW; McLellan LI Carcinogenesis; 2000 Oct; 21(10):1827-34. PubMed ID: 11023540 [TBL] [Abstract][Full Text] [Related]
14. Effect of high and low dietary protein on the dosing and postdosing periods of aflatoxin B1-induced hepatic preneoplastic lesion development in the rat. Appleton BS; Campbell TC Cancer Res; 1983 May; 43(5):2150-4. PubMed ID: 6131741 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875 [TBL] [Abstract][Full Text] [Related]
17. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Hayes JD; Judah DJ; McLellan LI; Kerr LA; Peacock SD; Neal GE Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):385-98. PubMed ID: 1953636 [TBL] [Abstract][Full Text] [Related]
18. Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine. Tsuda H; Sakata T; Masui T; Imaida K; Ito N Carcinogenesis; 1984 Apr; 5(4):525-31. PubMed ID: 6142774 [TBL] [Abstract][Full Text] [Related]